Investments
5Portfolio Exits
2
Want to inform investors similar to Epiphron Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Epiphron Capital News
Mar 2, 2021
YishengBio Co., Ltd., a Beijing, China-based fully integrated biopharmaceutical company, closed a US$130m Series B funding round.After completing the Series B funding round, the company’s institutional investors include: OrbiMed, Oceanpine, EightRoad, F-Prime Capital, 3W Capital, Hillhouse Capital, Adjuvant Capital, MSA Capital, AIHC, Epiphron Capital, Superstring Capital, Haitong International, etc.YishengBio’s YSJA™ rabies vaccine is the first alum-free lyophilized rabies vaccine launched in China.The rabies vaccine has been commercialized in China and has served over 16 million patients for post-exposure protection against rabies.Being able to accelerate post-exposure immune protection,PIKA rabies vaccine has the potential to lead in the rabies vaccines market in the future. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.
Epiphron Capital Investments
5 Investments
Epiphron Capital has made 5 investments. Their latest investment was in Clarapath as part of their Series B on November 11, 2021.
Epiphron Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
11/17/2021 | Series B | Clarapath | $32M | Yes | 3 | |
6/1/2021 | Series C | |||||
1/8/2020 | Series B | |||||
1/2/2019 | Series B | |||||
Other Investors |
Date | 11/17/2021 | 6/1/2021 | 1/8/2020 | 1/2/2019 | |
|---|---|---|---|---|---|
Round | Series B | Series C | Series B | Series B | Other Investors |
Company | Clarapath | ||||
Amount | $32M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 3 |
Epiphron Capital Portfolio Exits
2 Portfolio Exits
Epiphron Capital has 2 portfolio exits. Their latest portfolio exit was Transcenta Holding on September 29, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
9/29/2021 | IPO | Public | 2 | ||
Date | 9/29/2021 | |
|---|---|---|
Exit | IPO | |
Companies | ||
Valuation | ||
Acquirer | Public | |
Sources | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
